CYBIN INC. |
Market Closed -
Other stock markets
|
After market 23:30:18 | |||
| 0.35 USD | 0.00% |
|
0.354 | +1.14% |
Chart calendar Cybin Inc.
db776396b73fc59ddd3315234085d353.H9OYv8q9LAAxmV_gJO6ZkIH-1y3RsqzfN_FhPhOu6yI.WZr6ypiNXUhSry_RZYXf9ea94lWp48OGW7YzSCrFoE1Spcjpic5ESWbcEg~81aef586b8cf374f0101f4d4d7d52651
Upcoming events on Cybin Inc.
Past events on Cybin Inc.
| 16/04/2024 18:30 | Bloom Burton & Co. Healthcare Investor Conference |
| 19/03/2024 20:05 | Public Ventures Discovery Day |
| 13/03/2024 12:30 | CYB003 Phase 2 Trial Results Call |
| 04/03/2024 17:50 | TD Cowen Health Care Conference |
| 14/02/2024 12:34 | Q3 2024 Earnings Release |
| 02/12/2023 | American College of Neuropsychopharmacology Meeting - Poster Number: M32 |
| 02/12/2023 | American College of Neuropsychopharmacology Meeting - Poster Number: M83 |
| 02/12/2023 | American College of Neuropsychopharmacology Meeting - Poster Number: M147 |
| 30/11/2023 15:00 | R&D Day |
| 15/11/2023 00:16 | Q2 2024 Earnings Release |
| 10/11/2023 | Society for Neuroscience Meeting |
| 07/11/2023 14:00 | Milken Institute Future of Health Summit |
| 01/11/2023 15:00 | CYB003 Phase II Interim Results Call |
| 12/10/2023 18:00 | Annual General Meeting - M&A Vote |
| 11/10/2023 22:00 | Neuropsychiatric Drug Development Summit |
| 11/10/2023 17:00 | Jefferies Inaugural Biotech CNS/Neuro Summit |
| 28/09/2023 18:15 | Cantor Global Healthcare Conference - Panel |
| 28/08/2023 16:30 | Acquisition of Small Pharma Inc by Cybin, Inc Call |
| 14/08/2023 12:30 | Q1 2024 Earnings Release |
| 10/08/2023 16:00 | Canaccord Genuity Growth Conference |
Annual results
| Fiscal Period | March | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 | 0,86 0,59 46.94% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | 0,00 | -19,2 -14,7 -30.34% | -45,6 -42,6 -7.06% | -46,6 -43,7 -6.71% | -67,4 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 | -32,3 -24,6 -31.07% | -63,8 -59,3 -7.64% | -51,5 -50,8 -1.43% | -68,9 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 | -32,2 -26,4 -22.05% | -67,6 -59,2 -14.29% | -47,5 -47,0 -0.97% | -74,4 |
|
Net income Million CAD | Released Forecast Spread | -0,81 | -32,2 -33,4 3.68% | -67,6 -63,9 -5.89% | -47,5 -46,7 -1.72% | -74,3 |
|
EPS CAD | Released Forecast Spread | 0,00 | -0,32 -0,23 -41.17% | -0,40 -0,37 -8.11% | -0,26 -0,24 -9.09% | -0,24 |
| Announcement Date | 09/11/20 | 28/06/21 | 22/06/22 | 27/06/23 | - |
Quarterly results
| Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -12,0 -15,0 20.34% | -13,0 -10,0 -28.97% | -11,2 -10,1 -11.29% | -11,2 -10,7 -4.67% | -11,0 -11,6 5.13% | -13,2 -11,3 -16.15% | -12,6 -12,8 1.27% | -13,8 -12,7 -9.4% | -26,9 -13,6 -97.66% | -14,0 | -13,8 | -13,9 | -14,2 | -14,3 |
|
EBIT Million CAD | Released Forecast Spread | -16,5 -16,9 2.72% | -16,3 -15,9 -2.97% | -13,4 -16,5 18.73% | -12,3 -14,3 13.78% | -12,1 -13,2 8.08% | -13,7 -13,2 -3.78% | -12,7 -13,0 2.49% | -13,9 -12,7 -9.56% | -27,0 -13,8 -95.71% | -18,0 | -14,0 | -14,1 | -14,4 | -14,5 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -17,2 -16,6 -3.94% | -18,1 -15,5 -17.06% | -13,1 -16,1 18.92% | -9,97 -14,4 30.6% | -10,7 -13,2 18.35% | -13,7 -12,8 -7.57% | -14,5 -12,6 -15.36% | -11,9 -12,2 2.81% | -30,3 -14,0 -116.21% | -17,7 | -12,5 | -12,7 | -13,1 | -13,3 |
|
Net income Million CAD | Released Forecast Spread | -17,2 -16,5 -3.99% | -18,1 -15,6 -16.08% | -13,1 -16,7 21.99% | -10,0 -13,6 26.69% | -10,7 -13,3 19.19% | -13,7 -12,6 -8.64% | -14,5 -12,8 -13.82% | -11,9 -12,2 2.81% | -30,3 -14,0 -116.21% | -18,2 | -12,5 | -12,7 | -13,1 | -13,3 |
|
EPS CAD | Released Forecast Spread | -0,10 -0,10 -5.26% | -0,10 -0,09 -15.94% | -0,07 -0,09 22.22% | -0,06 -0,07 12.5% | -0,06 -0,07 14.29% | -0,07 -0,06 -16.67% | -0,07 -0,06 -20.01% | -0,05 -0,05 0% | -0,09 -0,04 -150% | -0,04 | -0,01 | -0,01 | -0,02 | -0,02 |
| Announcement Date | 10/02/22 | 22/06/22 | 08/08/22 | 14/11/22 | 14/02/23 | 27/06/23 | 14/08/23 | 14/11/23 | 14/02/24 | - | - | - | - | - |
More events
Past sector events for Cybin Inc.
| 03/05/2024 12:00 | GH RESEARCH PLC: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | ZYMEWORKS INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:02 | ARDELYX, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 02/05/2024 21:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release |
| 02/05/2024 16:00 | GENMAB A/S: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | GERON CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CYBN Stock
- Calendar Cybin Inc.
